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The oral cavity is a specialized ecological niche of the human body and forms a 
continuum with the digestive and respiratory system. The vastly diverse endogenous 
microbiota of the oral cavity is collectively referred to as the “oral microbiome”. It 
has been, and continues to be, explored by numerous cultivation or culture-
independent methods, yielding more than 600 individual taxa 1. They show tropism 
for different microhabitats, but may also show differential associations with oral 
health or disease. Commensal oral microbiota live in a symbiotic relationship with the 
host, which is crucial for the maintenance of oral health 2. Yet, disruption of this tight 
relationship by various factors will result in dysbiosis, allowing for the survival and 
establishment of a more virulent pathobiotic polymicrobial community that may 
impair the efficient immune response 3, 4. Clinically, these events could manifest as an 
oral infectious disease. 
A common oral disease of polymicrobial etiology is dental caries 5, whose 
incidence and progression rate has declined in recent years due to successfully 
introduced population-based prevention measures 6, 7. Progression of dental caries into 
the pulp space of the tooth will eventually cause pulpitis, and subsequently infection 
of the root canal space, leading to tooth necrosis. Expansion of the infection beyond 
the root canal and around the apex of the tooth may manifest as apical periodontitis, a 
condition associated with resorption of the periapical bone with formation of cysts 
and granulomas 8, 9. This can develop unnoticed by the patient for years, or be 
activated with painful symptoms. While there is consensus that the interplay between 
the resident microbiota and the local response of the immune system are modulating 
the course of disease, we still fail to understand when and why these infections are 
activated. Zehnder and Belibasakis discuss how recent advances in molecular 
microbiology have given new directions in our understanding of root canal infections, 
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and highlight the missing links between clinical experience and experimental 
observations on this topic 10.  
Periodontal diseases comprise a cluster of infectious inflammatory diseases 
that affect 10-15% of the global population in its severe form 11. Gingivitis is an 
initial form of periodontal disease, manifesting as inflammation restricted to the 
superficial gingival tissue. Once this inflammation is expanded to cause destruction of 
the deeper periodontal (tooth-supporting) tissues, it manifests as periodontitis, the 
major cause of tooth loss in adults. Periodontitis compromises quality of life and its 
treatment poses a significant financial burden on national health systems. 
Etiologically, it is the polymicrobial oral biofilms forming on the tooth surface 
that initiate inflammation, which may eventually become tissue-destructive. Yet, the 
dysbiotic host response to the biofims is invariably a crucial determinant of the 
pathogenesis of periodontitis 4. A well-studied bacterial species frequently associated 
with biofilms from periodontitis-affected sites is the Gram-negative anaerobe 
Porphyromonas gingivalis. It can effectively evade the immune responses and 
displays invasive capacities 12. Hence, it is featured as a “keystone” pathogen in 
manipulating the host’s immune response and causing dysbiosis 6, 13, 14. The several 
virulence factors by which P. gingivalis can subvert the function of leukocytes, 
enabling it to thrive in an inflammation-rich environment are reviewed by Zenobia 
and Hajishengallis 15. Tissue invasion by P. gingivalis may also be an important 
virulence property of this species. To this extent Baek et al. show that the invasive 
capacity of P. gingivalis isolates exhibits strong positive correlations with the clinical 
severity of periodontitis of the subjects who harbored the isolates 16. 
Among the bacteria highly associated with periodontitis is the Gram-negative 
Tannerella forsythia, a species with less well characterized virulence factors. Megson 
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et al have elucidated TfFuc1, a novel fucosidase expressed on its surface 17. This 
potential virulence factor may be linked to specific metabolic requirements of T. 
forsythia and its catalytic interactions with host proteins, potentially favoring its 
invasion properties. TfFuc1 is the first fucosidase to be identified in T. forsythia, and 
its biological roles warrant further investigation. 
While over the years several bacterial taxa have been identified and classified 
as “putative” oral pathogens, several recently identified species await further 
characterization.  As such, Streptococcus tigurinus, a novel species belonging to the 
Streptococcus mitis group, is discussed by Zbinden et al. on its association with other 
closely related streptococci, and whether there is evidence of its role in common oral 
infections 18. This is plausible given the association of S. tigurinus with severe 
medical infections, such as infective endocarditis, spondylodiscitis and meningitis 19. 
While there is at present only weak evidence on the involvement of S. tigurinus in 
periodontal diseases 20, its presence in the oral cavity and its association with invasive 
infections are of high interest with regards to potential links between oral and 
systemic infections. At this point it should also be noted that, beyond bacterial 
infections, viruses may also play a role in oral pathologies. One example is human 
papillomavirus (HPV) infection, which has been postulated as an etiological cause of 
head and neck squamous cell carcinoma. Hübbers and Akgül debate on whether HPV 
plays also a role in the development of squamous cell carcinoma of the oral cavity 21. 
Beyond the microbiological aspects, the immunological host response is a 
crucial element for the pathogenesis of oral infections. There is increasing evidence 
that specific genetic polymorphisms, or their combinations, confer increased 
susceptibility for periodontitis, or determine its progression rate 22. In a case-control 
study, Cavalla et al. monitored functional polymorphisms that result in the 
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transcriptional activity of the TBX21 gene, which regulates the Th-1 biased immune 
response 23. It was found that one of the polymorphic alleles (T) was more prevalent 
in chronic periodontitis, compared to gingivitis, but no association was found with 
presence of specific periodontal pathogens or clinical parameters of disease severity. 
While the prevalence of chronic periodontitis increases by age and affects 
particularly the elderly population, a form of the disease of special mention is 
aggressive periodontitis. This is a rapidly progressive form that occurs in young 
individuals, who run a high risk of losing their teeth at a young age. A limited number 
of longitudinal studies point to predictive factors for the onset and progression of the 
disease being both microbial and host genetic ones. The former is backed-up by the 
frequent presence of Aggregatibacter actinomycetemcomitans JP2 clone, a Gram-
negative facultative anaerobe, whereas the latter on the familial or ethnic aggregation 
of the disease. Hoglund Aberg et al. review the current knowledge on the association 
of A. actinomycetemcomitans with the risk for aggressive periodontitis, and discuss 
the role of its virulence factor leukotoxin in the pathogenesis of the disease 24. The 
role of the host response is further discussed by Nibali, who argues that the risk 
factors for aggressive periodontitis studied to-date apply only to a fragment of the 
cases. He reviews the evidence on the concept that genetically-driven dysbiotic 
changes in the subgingival biofilm microbiota may predispose to the rapid periodontal 
tissue destruction seen in aggressive periodontitis 25. 
Evidently, a number of questions regarding the etiological and pathogenic 
mechanisms of the periodontal diseases are not fully elucidated or under question. 
Mendes et al. review the available case-control studies on the relationship between 
bacterial invasion of the periodontal tissues and progression periodontitis 26. Due to 
the diversity in study protocols and methodological approaches employed, no 
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consistent association between specific periodontal pathogens was found across 
studies. Hence, it is concluded that there is insufficient evidence to support or exclude 
the invasion of periodontal pathogens as a crucial process in the etiopathogenesis of 
the disease. Lopez et al. take an epidemiological perspective to discuss whether there 
is enough evidence to support our current understanding of specific periodontal 
pathogens as causes of periodontitis 27. Once again, given the strong methodological 
heterogeneity among studies, there are obstacles in gauging the distribution of 
putative periodontal pathogens across age and ethnic populations or geographic 
locations, with only a minimal amount of studies supporting an association between 
specific pathogens and progression of periodontitis. From an epidemiological 
perspective, it is proposed that periodontitis is better understood as an inflammatory 
disease resulting from the interaction of many causal components, where microbes 
may as well be adopted. 
A special mention should be made to peri-implant infections. These have 
emerged following the routine use of osseointegrated dental implants in restorative 
dentistry. Implants provide the oral cavity with new artificial surfaces prone to the 
formation of biofilms, which can trigger the inflammatory destruction of the peri-
implant tissue, clinically manifesting as peri-implantitis. Periodontitis and peri-
implantitis feature qualitative similarities in the immune-pathological events that lead 
to their development, albeit the latter shows more pronounced inflammatory 
responses and rapid tissue destruction 28, 29. Charalampakis and Belibasakis review the 
current knowledge on the microbiology of peri-implant infections gained from 
various methodological approaches, discussing the benefits and limitations 30. While 
there are considerable similarities in microbial profiles between periodontal and peri-
 7
implant infections, there are also distinctive differences, which are expected to 
become more diversified with the increasing application of metagenomics platforms. 
Research in the field of periodontal (and potentially peri-implant) infections 
involves clinical, in vivo or in vitro models, all of which have specific limitations, but 
may also complement each other. Clinical studies bring along a number of complex 
biological and ethical considerations, whereas animal models do not fully recapitulate 
the complex processes that govern human periodontitis. Hajishengallis et al. argue 
that, despite their limitations, animal models are indispensable tools for the study of 
the etiopathogenesis of periodontal diseases 31. They are of particular value in testing 
the significance of biological mechanisms identified by in vitro studies, for 
consolidating cause-effect relationships deriving from clinical studies, and for testing 
novel therapeutic targets. In vitro experimental models tend to be over-simplistic, but 
on the other hand they allow for the dissection of finite biological mechanisms. In 
vitro oral biofilm models have attracted plenty of attention in recent years, 
particularly due to their usefulness in testing the efficacy of various anti-infective 
treatments 32, 33, prior to their application in pre-clinical models or clinical trials. They 
are also useful in studying aspects of microbial ecology, particularly by evaluating the 
role of different bacteria, or their virulence factors in the function and structure of the 
overall biofilm community 34-36. Thurnheer and Belibasakis have utilized an in vitro 
biofilm model of six oral species, in order to test if bacteria that are not part of the 
normal oral microbiota (Eschericia coli, Staphylococcus aureus, Enterococcus 
faecails) can efficiently colonize and grow within oral biofilms 37. Indeed these 
species were able to grow efficiently and in various structural conformations within 
this oral biofilm model. A derivative of this biofilm can also be used in more complex 
tissue-biofilm interaction models, in order to study the host response mechanisms of 
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relevance to periodontal disease 38-40. Bao et al. established such an oral infection 
model resembling the periodontal pocket in a perfusion bioreactor system, which 
recapitulates key biological events of periodontal pathogenesis and may reduce the 
need for experimental animal models in the future 41. 
The treatment of oral infections can pose important difficulties, as these are 
primarily biofilm-related diseases. Biofilms are considerably more resistant against 
common antimicrobials treatments, compared to bacteria in their planktonic state. On 
the other hand, the routine use of antibiotics in common oral infections, such as 
periodontitis, is not ideal due to the increase in antibiotic resistance and other adverse 
effects. Allaker and Douglas discuss on the possibilities of non-conventional targeted 
approaches against biofilm-associated oral infections 42. These include targeting a 
single species in the biofilm or its virulence factors, whilst maintaining the remaining 
of the oral microbiota. They may involve photodynamic therapy, enzyme inhibitors, 
enzymes and detergents, probiotics and prebiotics, as well as antimicrobial peptides 
and nanoparticles. 
In summary, this Special Focus issue on “Oral Infections” aspires to highlight 
current knowledge on oral infectious diseases, while bringing forward advances in the 
fields of oral microbiology and immunology. Although over the years we have 
gathered important scientific information on periapical and periodontal infections, 
these still constitute important human health issues that may pose therapeutic 
challenges. At the same time, the more aggressive and less well-studied peri-implant 
infections are emerging as a future challenge for practitioners and researchers, due to 
the ever-increasing implementation of dental implants in practice. At this point, it is 
important express the notion that prevention strategies of oral infections will be on 
long term considerably more efficacious than their treatment. Hence, there is a need 
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for personalized dental healthcare and monitoring, in order to identify healthy 
individuals albeit at disease risk, reach an early diagnosis prior to clinical disease 
manifestation, and improve the prognosis of treatment outcomes. Last but not least, 
we should consider that the oral cavity is inseparably linked to the human body, and 
that the oral health may well affect the systemic health status, and vice versa. 
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